[1] Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS[J]. AIDS, 2009, 23(4):525-530. [2] Idnurm A, Bahn YS, Nielsen K, et al. Deciphering the model pathogenic fungus Cryptococcus neoformans[J]. Nat Rev Microbiol, 2005, 3(10):753-764. [3] Wickes BL, Edman JC. The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter[J]. Mol Microbiol, 1995, 16(6):1099-1109. [4] Ory JJ, Griffith CL, Doering TL. An efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter[J].Yeast, 2004, 21(11):919-926. [5] del PM, Toffaletti DL, Rude TH, et al. Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein[J]. Infect Immun, 1999, 67(4):1812-1820. [6] Fang W, Price MS, Toffaletti DL, et al.Pleiotropic effects of deubiquitinating enzyme Ubp5 on growth and pathogenesis of Cryptococcus neoformans[J]. PLoS One, 2012, 7(6):e38326. [7] Chayakulkeeree M, Rude TH, Toffaletti DL, et al. Fatty acid synthesis is essential for survival of Cryptococcus neoformans and a potential fungicidal target[J]. Antimicrob Agents Chemother, 2007, 51(10):3537-3545. [8] Cox GM, Rude TH, Dykstra CC, et al. The actin gene from Cryptococcus neoformans: structure and phylogenetic analysis[J]. J Med Vet Mycol, 1995, 33(4):261-266. [9] Kingsbury JM, McCusker JH. Threonine biosynthetic genes are essential in Cryptococcus neoformans[J]. Microbiology, 2008, 154(Pt 9):2767-2775. [10] Wang L, Zhai B, Lin X. The link between morphotype transition and virulence in Cryptococcus neoformans[J]. PLoS Pathog, 2012, 8(6):e1002765. [11] Price MS, Betancourt-Quiroz M, Price JL, et al. Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host[J]. MBio, 2011, 2(3):e00103-00111. [12] Finley D, Ciechanover A, Varshavsky A. Ubiquitin as a central cellular regulator[J]. Cell, 2004, 116(2 Suppl):S29-32, 2 p following S32. [13] Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes[J]. Biochim Biophys Acta, 2004, 1695(1-3):189-207. [14] Liu OW, Chun CD, Chow ED, et al. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans[J]. Cell, 2008, 135(1):174-188. [15] Leach MD, Stead DA, Argo E, et al. Molecular and proteomic analyses highlight the importance of ubiquitination for the stress resistance, metabolic adaptation, morphogenetic regulation and virulence of Candida albicans[J]. Mol Microbiol, 2011, 79(6):1574-1593. [16] Spitzer ED, Spitzer SG. Structure of the ubiquitin-encoding genes of Cryptococcus neoformans[J]. Gene, 1995, 161(1):113-117. |